单击此处阅读完整的文章。 前细胞感染微生物。 2023; 13：1254198。 EPUB 2023 8月18日。PMID： 37662007“> 37662007 Yifan Jiang, Zhimin Xu, Renqiang Yu Yijing PengAbstract: OBJECTIVES: Digestive system diseases have evolved into a growing global burden without sufficient therapeutic measures.() is considered as a new potential economical therapy for its胃肠系统中的益生菌作用。我们已经提供了支持各种环境应用程序来处理常见消化系统D的研究概述。iseases, including infantile colic, diarrhea, constipation, functional abdominal pain,infection, inflammatory bowel disease, diverticulitis, colorectal cancer and liver diseases. METHODS: The summarized literature in this review was derived from databases including PubMed, Web of Science, and Google学者。 结果： 消化系统疾病的治疗效应可能取决于各种直接和间接机制，包括代谢物的产生，包括肠道微生物组的调节以及肠道微生物组的调节，对肠道的保存和肠道系统的保存和调节，并进行了构成和调节。这些动作在很大程度上是应变特异性的，并且取决于对各种某些信号途径的激活或抑制。可以很好地证明可以有效作为一种预防措施，也可以作为婴儿绞痛的首选治疗方法，也可以建议作为索克万腹泻，便秘，感染的t策略。 While preclinical studies have shown the probiotic potential ofin the management of functional abdominal pain, inflammatory bowel disease, diverticulitis, colorectal cancer and liver diseases, its application in these disease settings still needs further study. CONCLUSION: This review focuses on the probiotic effects ofon gut homeostasis via certain信号通路，并强调这些益生菌作为对几种消化系统疾病的前瞻性治疗的重要性。